| Literature DB >> 30790465 |
Xiao-Feng Xiong1,2, Hang Zhang1,3, Michael W Boesgaard1, Christina R Underwood1, Hans Bräuner-Osborne1, Kristian Strømgaard1.
Abstract
G proteins act as molecular switches in G protein-coupled receptor signaling pathways and are key mediators for numerous important physiological processes. The natural product, cyclic depsipeptide YM-254890, together with the structurally similar FR900359, is the only known selective inhibitor of the Gq/11 subfamily of G proteins. We recently reported the first total synthesis of YM-254890 and FR900359, followed by synthesizing analogues to perform structure-activity relationship studies. However, incomplete information about their structure-activity relationship prevents the further development of potent and structurally simplified analogues. Herein we report the first systematic structure-activity relationship study toward the N-methyldehydroalanine moiety in YM-254890, by designing and synthesizing seven new analogues. Pharmacological characterization of the seven compounds for Gq/11 -, Gi/o - and Gs -mediated signaling showed that the simplified analogue YM-19 is the most potent Gq/11 inhibitor among the new analogues. This study provides information for the future design of potent and simplified YM-254890 analogues.Entities:
Keywords: G protein inhibitors; G protein-coupled receptors; G proteins; YM-254890; structure-activity relationships
Year: 2019 PMID: 30790465 DOI: 10.1002/cmdc.201900018
Source DB: PubMed Journal: ChemMedChem ISSN: 1860-7179 Impact factor: 3.466